Hong Qiu
- Cancer Research top 10%
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 3
-
- Glycosylation and Glycoproteins Research 3
- Cell Biology top 10%
- Proteoglycans and glycosaminoglycans research 6
- Aquatic Science top 10%
- Pharmacology top 10%
-
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 3
-
- Nitric Oxide and Endothelin Effects 3
-
- Liver physiology and pathology 3
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Hong Qiu
55 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 122
- Cancer Research 216
- Molecular Biology 625
- Cell Biology 125
- Aquatic Science 53
- Pharmacology 113
Countries citing papers authored by Hong Qiu
This map shows the geographic impact of Hong Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Qiu more than expected).
Fields of papers citing papers by Hong Qiu
This network shows the impact of papers produced by Hong Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Qiu. The network helps show where Hong Qiu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hong Qiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 7 | |
| 5 | 2022 | 18 | |
| 6 | 2022 | 8 | |
| 7 | 2021 | 43 | |
| 8 | 2021 | 6 | |
| 9 | 2021 | 3 | |
| 10 | 2020 | 5 | |
| 11 | 2015 | 19 | |
| 12 | 2014 | 8 | |
| 13 | 2013 | 9 | |
| 14 | 2013 | 52 | |
| 15 | 2009 | 7 | |
| 16 | 2009 | 17 | |
| 17 | 2007 | 75 | |
| 18 | 2004 | 19 | |
| 19 | 2002 | 8 | |
| 20 | 1996 | 0 |
About Hong Qiu
Hong Qiu is a scholar working on Cancer Research, Cell Biology and Hepatology, having authored 59 papers that have together received 1.4k indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Nitric Oxide and Endothelin Effects (3 papers), Liver physiology and pathology (3 papers), Glycosylation and Glycoproteins Research (3 papers), COVID-19 Clinical Research Studies (3 papers), MicroRNA in disease regulation (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (216 citations), Molecular Biology (625 citations) and Cell Biology (125 citations). Hong Qiu has collaborated with scholars based in China, United States and France. Frequent co-authors include Kan Ding, Lianchun Wang, Qun Dong, Wei Tang, Jianping Zuo, Xiankun Tong, Hongyan Tian, Xing Pei, Jie Geng and Yong Han.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.